Ian Rentsch | GM Pharma
Centogene

Ian Rentsch has over 25 years’ experience in Multinational Corporate Affairs, Outsourcing Management, Clinical Research Development , Real World Data generation & Healthcare Technology Solutions working in large multinational companies as well as in Start Ups both Globally out of Europe as well as in Emerging Markets such as Latin America. Started his career at Hoechst (German Pharma) in 1996 in the Legal Department and progressed his legal career over 10 years all in German Multinational Companies before starting in Clinical Research 15 years ago in leadership positions at CROs both Regionally as well as Globally such as in Progenitor Intl Research, Encorium Oy , Quintiles / IQVIA and as well being the CEO of Clinerion in Switzerland for three years until 2021 before its exit to INFORMA Pharma Intelligence. Most recently and after 1 year as Vice President Growth / Strategic Partnerships at AETION Inc, moved in March 2022 into the Exec Leadership team of TRINETX leading M&A and Strategic Partnerships as Chief Business Officer and most recently to CENTOGENE as CCO & GM Pharma since early 2023.